Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesDigital X-RayDEXA receives major boost for osteoporosis screeningGreater emphasis looks set to be put on the use of dual-energy x-ray absorptiometry (DEXA) for osteoporosis screening.MRIML model using CCTA, MRI data predicts MACE in cardiac patientsClinical NewsPatient death prompts RCR to act on gastric bandsMRIGenetic testing, risk assessment tied to more breast MRI uptakeMolecular ImagingPET scans can reduce unnecessary lymph node procedures